2014 Taubman Prize

For Excellence in Translational Medical Science

This award is presented annually by the A. Alfred Taubman Medical Research Institute at the University of Michigan. It is meant to recognize work in the crucial field of translational research being conducted by the clinician-scientist who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease.


Prize: $100,000

Eligibility:

  • International scientists are eligible.
  • U-M scientists are excluded.
  • Self-nomination is permitted.
  • The recipient must be available to deliver the keynote speech at the Taubman Institute annual symposium Oct. 10, 2014 in Ann Arbor, Mich.

Judging Criteria:

  • Significant contribution to translating basic research findings into medical practice
  • The manner in which nominee’s clinical activities connects to his or her laboratory research

Deadline: February 1, 2014

Nomination Guidelines

For a nomination to be considered by the selection committee, the following items must be submitted with the completed nomination form:

  • A one-page letter of nomination detailing the individual’s extraordinary or sustained contribution to the field of translational research
  • The curriculum vitae of the nominee
  • A bibliography of 5 most significant publications
  • Two additional letters of support

Electronic submissions are encouraged. Incomplete nominations will not be presented to the nomination committee.

button-nomination

If you have any questions, please email This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists